FDA
Clears New Continuous Blood Pressure Technology From Sotera Wireless. The ViSi Mobile
System is the first wrist-worn monitor to measure all core patient vital
signs: continuous non-invasive blood pressure (cNIBP), heart rate or pulse
rate, electrocardiogram (ECG), blood oxygenation level, respiration rate and
skin temperature, with the accuracy of systems used in hospital intensive
care units. Wireless technology transmits vital sign data, enabling
clinicians to monitor measurements on remote viewing or notification devices.
The system incorporates safety features, such as an advanced alarm management
system that notifies clinicians of unfavorable changes in a patient's
condition, enabling early intervention if needed
Full
Press Release Below.
SOURCE:
Sotera Wireless
FDA Clears New Continuous Blood Pressure
Technology From Sotera Wireless.
First FDA Clearance of Passive, Non-Invasive
Technique Could Transform Cardiovascular Medicine
SAN DIEGO, Oct. 10, 2013 /PRNewswire/
-- Sotera® Wireless, Inc. today announced the U.S. Food and
Drug Administration has cleared the Company's patented continuous
non-invasive blood pressure (cNIBP) technology, a new feature of the ViSi
Mobile® wireless patient monitoring system. For the first time
clinicians can continuously monitor all patient vital signs, including
beat-to-beat blood pressure, without the use of a catheter or blood pressure
cuff.
Physicians can use cNIBP measurements to better
manage patients with hypertension, commonly known as high blood pressure.
Hypertension affects 67 million, or one in three, American adults resulting
in a direct healthcare cost of approximately $50 billion.
In the United States, hypertension is present in
69 percent of people who have a first heart attack, 77
percent of people who have a first stroke, and 74 percent of
people with chronic heart failure, placing it among the most dangerous risk
factors for cardiovascular disease.
Numerous studies point to the benefits of
beat-to-beat blood pressure monitoring, but obtaining accurate continuous
data currently requires catheter insertion, exposing patients to discomfort
and risk of infection. Sotera's cNIBP technology maximizes comfort and safety
by obtaining measurements without invasive procedures or the frequent use of
a blood pressure cuff. In studies comparing the clinically validated cNIBP
technology with invasive arterial line procedures cNIBP technology
demonstrated a bias of less than 5 mmHg.
"Blood pressure is one of the most important
vital signs and yet it is considerably undervalued, largely because most
clinicians are limited to periodic cuff-based measurements," said Tom
Watlington, Sotera chief executive officer. "By providing data collected
around the clock without disrupting a patient's sleep, we believe the ViSi
Mobile System with cNIBP will help improve diagnosis and management of
hypertension, saving lives and dollars."
The ViSi Mobile System is the first wrist-worn
monitor to measure all core patient vital signs: cNIBP, heart rate or pulse
rate, electrocardiogram (ECG), blood oxygenation level, respiration rate and
skin temperature, with the accuracy of systems used in hospital intensive
care units. Wireless technology transmits vital sign data, enabling
clinicians to monitor measurements on remote viewing or notification devices.
The system incorporates safety features, such as an advanced alarm management
system that notifies clinicians of unfavorable changes in a patient's
condition, enabling early intervention if needed.
About Sotera Wireless
. Sotera Wireless, Inc. is a San Diego based
medical device company dedicated to the development, marketing and sale of a
new generation of comprehensive vital signs monitoring. Sotera's mission is
to improve patient safety by empowering clinicians to detect early signs of
deterioration in virtually any care setting and enable early intervention and
rapid response, all without limiting the patient's freedom of movement. More
information on the company or its ViSi Mobile System can be obtained at www.soterawireless.com or by sending an
email to info@soterawireless.com.
Sotera® and ViSi Mobile®
are registered trademarks of Sotera Wireless, Inc.
SOURCE Sotera Wireless, Inc.
CONTACT: Sotera Wireless, Inc., Tom Watlington,
Chief Executive Officer, +1-619-427-4629
Web Site: http://www.soterawireless.com
|
Thursday, October 10, 2013
FDA Clears New Continuous Blood Pressure Technology
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment